ID   TE 671 Subline No.2
AC   CVCL_2731
SY   TE671 Subline No.2; TE671 Subline 2; TE671 Line, subline 2
DR   CLO; CLO_0009318
DR   CLDB; cl4499
DR   CLDB; cl4500
DR   ATCC; CRL-8805
DR   BCRC; 60324
DR   BioSample; SAMN03151902
DR   cancercelllines; CVCL_2731
DR   CCRID; 1101HUM-PUMC000266
DR   ECACC; 94052610
DR   ICLC; HTL97021
DR   KCLB; 28805
DR   Wikidata; Q54971991
RX   Patent=US4789640;
RX   PubMed=2739733;
RX   PubMed=2911385;
RX   PubMed=2993532;
RX   PubMed=20143388;
WW   Info; ATCC; -; https://www.atcc.org/en/support/technical-support/faqs/te671-sub-line-2-atcc-crl-8805
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Group: Patented cell line.
CC   Problematic cell line: Contaminated. Parent cell line (TE 671) has been shown to be a RD derivative (PubMed=2739733; PubMed=20143388).
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00347.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8805.
CC   Population: Caucasian.
CC   Doubling time: 27 hours (PubMed=2993532).
CC   Sequence variation: Mutation; HGNC; HGNC:7989; NRAS; Simple; p.Gln61His (c.183A>T); ClinVar=VCV000373003; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg248Trp (c.742C>T); ClinVar=VCV000012347; Zygosity=Homozygous (from parent cell line).
CC   Discontinued: ATCC; CRL-8805; true.
CC   Discontinued: BCRC; 60324; true.
CC   Discontinued: ECACC; 94052610; true.
CC   Derived from site: In situ; Pelvis, muscle; UBERON=UBERON_0001325.
ST   Source(s): ATCC=CRL-8805; CCRID=1101HUM-PUMC000266
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 13
ST   D16S539: 10,11
ST   D18S51: 13
ST   D19S433: 11,14
ST   D21S11: 28,29
ST   D2S1338: 23
ST   D3S1358: 15,17
ST   D5S818: 10,11
ST   D7S820: 8,12
ST   D8S1179: 11,15
ST   FGA: 20,21
ST   TH01: 9.3
ST   TPOX: 9
ST   vWA: 18
DI   NCIt; C8971; Embryonal rhabdomyosarcoma
DI   ORDO; Orphanet_99757; Embryonal rhabdomyosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1756 ! TE 671
SX   Female
AG   7Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 32
//
RX   Patent=US4789640;
RA   Lindstrom, Jon M.
RT   "Assays for myasthenia gravis.";
RL   Patent number US4789640, 06-Dec-1988.
//
RX   PubMed=2911385; DOI=10.1038/337311c0;
RA   Stratton, Michael Rudolf
RA   Reeves, Brian R.
RA   Cooper, Colin S.
RT   "Misidentified cell.";
RL   Nature 337:311-312(1989).
//
RX   PubMed=2993532; DOI=10.1097/00005072-198509000-00003;
RA   Jacobsen, Phillip F.
RA   Jenkyn, Dorothy Joy
RA   Papadimitriou, John M.
RT   "Establishment of a human medulloblastoma cell line and its
RT   heterotransplantation into nude mice.";
RL   J. Neuropathol. Exp. Neurol. 44:472-485(1985).
//
RX   PubMed=20143388; DOI=10.1002/ijc.25242;
RA   Capes-Davis, Amanda
RA   Theodosopoulos, George
RA   Atkin, Isobel
RA   Drexler, Hans Gunther
RA   Kohara, Arihiro
RA   MacLeod, Roderick A.F.
RA   Masters, John R.W.
RA   Nakamura, Yukio
RA   Reid, Yvonne A.
RA   Reddel, Roger Robert
RA   Freshney, Robert Ian
RT   "Check your cultures! A list of cross-contaminated or misidentified
RT   cell lines.";
RL   Int. J. Cancer 127:1-8(2010).
//
RX   PubMed=2739733; DOI=10.1038/340106b0;
RA   Chen, Tchaw-Ren
RA   Dorotinsky, Catherine S.
RA   Macy, Marvin L.
RA   Hay, Robert J.
RT   "Cell identity resolved.";
RL   Nature 340:106-106(1989).
//